Ledger.Open graph →
SEC Form D · filed November 29, 2022

Gila Therapeutics, Inc

Offering
$5.0M
Sold
$356K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MINNEAPOLIS, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Timothy Barberich · Boston, MADirectorScott Schorer · Boston, MAExec · DirectorChristopher De Souza · Boston, MADirectorJon Freeman · Minneapolis, MNExecRichard Horan · Providence, RIDirectorScott Schorer · Boston, MAExec · DirectorTimothy Barberich · Framingham, MADirectorChristopher De Souza · Boston, MADirectorJon Freeman · Maple Grove, MNExecRichard Horan · Providence, RIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗